Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size, Status and Forecast 2022
- QYR1051566
- 91 Pages
- March 2017
- Medical Devices
This report studies the global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market, analyzes and researches the Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Takeda Pharmaceutical
Merck
AstraZeneca
GlaxoSmithKline
Pfizer
Cubist Pharmaceuticals
ViroPharma
Forest Laboratories
Theravance
Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia
Market segment by Type, Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs can be split into
Bactrim
Vancomycin
Clindamycin
Minocycline
Market segment by Application, Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs can be split into
Healthcare-Associated MRSA
Community-Associated MRSA
Livestock-Associated MRSA
Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size, Status and Forecast 2022
1 Industry Overview of Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs
1.1 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Overview
1.1.1 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market by Type
1.3.1 Bactrim
1.3.2 Vancomycin
1.3.3 Clindamycin
1.3.4 Minocycline
1.4 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market by End Users/Application
1.4.1 Healthcare-Associated MRSA
1.4.2 Community-Associated MRSA
1.4.3 Livestock-Associated MRSA
2 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Competition Analysis by Players
2.1 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Takeda Pharmaceutical
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Merck
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 AstraZeneca
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 GlaxoSmithKline
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Pfizer
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Cubist Pharmaceuticals
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 ViroPharma
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Forest Laboratories
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Theravance
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue (Value) (2012-2017)
3.9.5 Recent Developments
4 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size by Type and Application (2012-2017)
4.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size by Type (2012-2017)
4.2 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size by Application (2012-2017)
4.3 Potential Application of Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs in Future
4.4 Top Consumer/End Users of Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs
5 United States Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Development Status and Outlook
5.1 United States Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (2012-2017)
5.2 United States Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size and Market Share by Players (2016 and 2017)
6 EU Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Development Status and Outlook
6.1 EU Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (2012-2017)
6.2 EU Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size and Market Share by Players (2016 and 2017)
7 Japan Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Development Status and Outlook
7.1 Japan Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (2012-2017)
7.2 Japan Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size and Market Share by Players (2016 and 2017)
8 China Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Development Status and Outlook
8.1 China Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (2012-2017)
8.2 China Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size and Market Share by Players (2016 and 2017)
9 India Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Development Status and Outlook
9.1 India Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (2012-2017)
9.2 India Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size and Market Share by Players (2016 and 2017)
10 Southeast Asia Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Development Status and Outlook
10.1 Southeast Asia Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (2012-2017)
10.2 Southeast Asia Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size and Market Share by Players (2016 and 2017)
11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Value) by Regions (2017-2022)
11.1.1 United States Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue and Growth Rate (2017-2022)
11.1.2 EU Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue and Growth Rate (2017-2022)
11.1.3 Japan Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue and Growth Rate (2017-2022)
11.1.4 China Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue and Growth Rate (2017-2022)
11.1.5 India Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue and Growth Rate (2017-2022)
11.2 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Value) by Type (2017-2022)
11.3 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size by Application (2017-2022)
12 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Dynamics
12.1 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Opportunities
12.2 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
Figure Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product Scope
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) (2012-2017)
Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Share by Regions in 2016
Figure United States Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Share by Type in 2016
Figure Bactrim Market Size (Million USD) and Growth Rate (2012-2017)
Figure Vancomycin Market Size (Million USD) and Growth Rate (2012-2017)
Figure Clindamycin Market Size (Million USD) and Growth Rate (2012-2017)
Figure Minocycline Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Share by Application in 2016
Figure Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) and Growth Rate in Healthcare-Associated MRSA (2012-2017)
Figure Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) and Growth Rate in Community-Associated MRSA (2012-2017)
Figure Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) and Growth Rate in Livestock-Associated MRSA (2012-2017)
Table Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) by Players (2016 and 2017)
Figure Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size Share by Players in 2016
Figure Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size Share by Players in 2017
Table Takeda Pharmaceutical Basic Information List
Table Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Business Revenue (Million USD) of Takeda Pharmaceutical (2012-2017)
Figure Takeda Pharmaceutical Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Business Revenue Market Share in 2016
Table Merck Basic Information List
Table Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Business Revenue (Million USD) of Merck (2012-2017)
Figure Merck Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Business Revenue Market Share in 2016
Table AstraZeneca Basic Information List
Table Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Business Revenue (Million USD) of AstraZeneca (2012-2017)
Figure AstraZeneca Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Business Revenue Market Share in 2016
Table GlaxoSmithKline Basic Information List
Table Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Business Revenue (Million USD) of GlaxoSmithKline (2012-2017)
Figure GlaxoSmithKline Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Business Revenue Market Share in 2016
Table Pfizer Basic Information List
Table Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Business Revenue (Million USD) of Pfizer (2012-2017)
Figure Pfizer Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Business Revenue Market Share in 2016
Table Cubist Pharmaceuticals Basic Information List
Table Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Business Revenue (Million USD) of Cubist Pharmaceuticals (2012-2017)
Figure Cubist Pharmaceuticals Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Business Revenue Market Share in 2016
Table ViroPharma Basic Information List
Table Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Business Revenue (Million USD) of ViroPharma (2012-2017)
Figure ViroPharma Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Business Revenue Market Share in 2016
Table Forest Laboratories Basic Information List
Table Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Business Revenue (Million USD) of Forest Laboratories (2012-2017)
Figure Forest Laboratories Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Business Revenue Market Share in 2016
Table Theravance Basic Information List
Table Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Business Revenue (Million USD) of Theravance (2012-2017)
Figure Theravance Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Business Revenue Market Share in 2016
Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) by Type (2012-2017)
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size Share by Type in 2012
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size Share by Type in 2013
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size Share by Type in 2014
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size Share by Type in 2015
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size Share by Type in 2016
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size Share by Type in 2017
Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) by Application (2012-2017)
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) by Application in 2012
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) by Application in 2013
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) by Application in 2014
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) by Application in 2015
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) by Application in 2016
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs
Figure United States Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) by Players (2012-2017)
Figure United States Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size Share by Players in 2016
Figure United States Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size Share by Players in 2017
Figure EU Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) by Players (2012-2017)
Figure EU Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size Share by Players in 2016
Figure EU Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size Share by Players in 2017
Figure Japan Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) by Players (2012-2017)
Figure Japan Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size Share by Players in 2016
Figure Japan Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size Share by Players in 2017
Figure China Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) by Players (2012-2017)
Figure China Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size Share by Players in 2016
Figure China Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size Share by Players in 2017
Figure India Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) by Players (2012-2017)
Figure India Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size Share by Players in 2016
Figure India Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size Share by Players in 2017
Figure Southeast Asia Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size Share by Players in 2016
Figure Southeast Asia Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size Share by Players in 2017
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) by Regions (2017-2022)
Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) by Regions (2017-2022)
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size Share by Regions in 2017
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size Share by Regions in 2022
Figure United States Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) by Type (2017-2022)
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size Share by Type in 2017
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size Share by Type in 2022
Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) by Application (2017-2022)
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) by Application in 2017
Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size (Million USD) by Application in 2022
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
